Sanjaya Singh

Sanjaya Singh

Directeur/Membre du Conseil chez SYNGENE INTERNATIONAL LIMITED
Health Technology
Commercial Services
Consumer Services

Profil

Sanjaya Singh is the founder of Third Arc Bio, Inc., founded in 2022, serving as Chief Scientific Officer.
Dr. Singh is also the founder of Aliada Therapeutics, Inc...
Dr. Singh is an Independent Non-Executive Director at Syngene International Ltd. since 2025.
Dr. Singh is a Venture Partner at Omega Fund Management LLC since 2023.
Dr. Singh was Director at Tanox, Inc. from 2000 to 2007.
Dr. Singh was Director & Vice President at C.H.
Boehringer Sohn AG & Co. KG from 2007 to 2016.
Dr. Singh was Vice President & Global Head at Janssen Pharmaceuticals, Inc. from 2016 to 2021.
Dr. Singh earned a doctorate from Banaras Hindu University.

Postes actifs de Sanjaya Singh

SociétésPosteDébut
SYNGENE INTERNATIONAL LIMITED Directeur/Membre du Conseil 01/07/2025
Fondateur -
Consultant / Advisor 01/06/2023

Anciens postes connus de Sanjaya Singh

SociétésPosteFin
Private Equity Investor 31/12/2021
Directeur/Membre du Conseil 30/09/2016
Directeur/Membre du Conseil 31/05/2007
Voir l'expérience en détail de Sanjaya Singh

Formation de Sanjaya Singh

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

27

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Sanjaya Singh
🔇